MNV-201 is also being studied in a Phase Ib for low-risk Myelodysplastic Syndrome; Preliminary clinical data demonstrate ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

Discover the hidden health issues often misdiagnosed as anxiety that could be causing your symptoms, from thyroid disorders ...

Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company"), a global biopharmaceutical company, and Shilpa Medicare Limited ("Shilpa") today announced the U.S. launch of BORUZUtm, a new presentation of ...

SAN FRANCISCO, Agusan del Sur (MindaNews / 29 March) — When Rogelio Timbal tends his one-hectare rice field in Barangay ...

Q4 2024 Earnings Call Transcript March 25, 2025 Corvus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.18 EPS, expectations were $-0.12. Operator: Good afternoon, everyone.

This may result in a lack of red blood cells (anemia), white blood cells (leukopenia), and platelets ... These cells go down separate pathways as they differentiate into red blood cells, platelets, ...

Thrombocytopenia secondary to iron deficiency anemia responding to iron therapy ... Melatonin promotes bone marrow mesenchymal stem cell osteogenic differentiation and prevents osteoporosis ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor (PPDPF) gene is a risk factor for chronic kidney disease (CKD), a multiomic study revealed. “These findings ...

Aggressive RCC subtypes, such as sarcomatoid tumors increased death risk by 2.3-fold. Poorly differentiated and undifferentiated tumors increased all-cause mortality by 1.2- and 1.6-fold ...